[PDF][PDF] A systematic overview of radiation therapy effects in prostate cancer

S Nilsson, BJ Norlén, A Widmark - Acta Oncologica, 2004 - Citeseer
A systematic review of radiation therapy trials in prostate cancer has been performed
according to principles adopted by the Swedish Council of Technology Assessment in …

Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials

DLC Kee, J Gal, AT Falk, R Schiappa, ME Chand… - Cancer treatment …, 2018 - Elsevier
Background Brachytherapy boost after external beam radiotherapy for intermediate and high-
risk prostate cancer is presented as an attractive technique in numerous retrospective and …

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

T Hambrock, DM Somford, HJ Huisman, IM van Oort… - Radiology, 2011 - pubs.rsna.org
Purpose To retrospectively determine the relationship between apparent diffusion
coefficients (ADCs) obtained with 3.0-T diffusion-weighted (DW) magnetic resonance (MR) …

Prostate cancer, version 2.2014

JL Mohler, PW Kantoff, AJ Armstrong… - Journal of the National …, 2014 - jnccn.org
Prostate cancer has surpassed lung cancer as the most common cancer in men in the
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …

Radical prostatectomy, external beam radiotherapy< 72 Gy, external beam radiotherapy≥ 72 Gy, permanent seed implantation, or combined seeds/external beam …

PA Kupelian, L Potters, D Khuntia, JP Ciezki… - International Journal of …, 2004 - Elsevier
PURPOSE: To review the biochemical relapse-free survival (bRFS) rates after treatment with
permanent seed implantation (PI), external beam radiotherapy (EBRT)< 72 Gy (EBRT< 72) …

Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation

MJ Zelefsky, DA Kuban, LB Levy, L Potters… - International Journal of …, 2007 - Elsevier
Purpose: To assess long-term prostate-specific antigen (PSA) outcome after permanent
prostate brachytherapy (BT) and identify predictors of improved disease-free survival …

Prostate cancer, version 3.2012 featured updates to the NCCN guidelines

JL Mohler, AJ Armstrong, RR Bahnson… - Journal of the National …, 2012 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer
provide multidisciplinary recommendations for the clinical management of patients with …

Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland

GS Merrick, KE Wallner, WM Butler - The Journal of urology, 2003 - Elsevier
PURPOSE: We summarize the permanent prostate brachytherapy literature, including
biochemical outcomes, quality of life parameters and areas of controversy. MATERIALS …

Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer

S Machtens, R Baumann, J Hagemann… - World journal of …, 2006 - Springer
Permanent interstitial brachytherapy represents the most conformal form of radiation therapy
of the prostate and the number of patients with prostate cancers treated with permanent …

Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy

MJ Zelefsky, Y Yamada, C Marion, S Sim… - International Journal of …, 2003 - Elsevier
Purpose: We have developed an intraoperative three-dimensional (3D) conformal treatment
planning system for permanent prostate implantation in an effort to reduce toxicity further …